September 14—Baltimore, Maryland— Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”
Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”
The role of in-house counsel varies in responsibilities, in some companies the focus is on litigation related activities, in others the focus is on compliance and government relations. It is not unusual for the in-house counsel to also work closely with the CEO and HR teams on employee issues. The start-up cannabis company has many needs, but also has evolving needs. The role of in-house counsel may start out in an advisory role to the CEO acting as a Swiss army knife of functionality on any topic that comes up. As the company grows, the needs will change and more narrowly focused, strategic activity for the in-house counsel will. This discussion will cover the varied and evolving in-house counsel role.
Scheril Murray Powell, Esq., is an agricultural, cannabis, and dietary supplement attorney at Doumar, Allsworth, Laystrom, Voigt, Adair, and Dishowitz LLP. Scheril also serves as the Director of Business Development of Creative Services, a FCRA compliance, background screening, and security firm. The Daily Business Review has named her one of the Top 12 cannabis attorney’s in Florida. Her practice covers both the marijuana and hemp industries, specializing in cannabinoid legalization and UK novel foods registration.
For more information on the hemp track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.